Ezetimibe (SCH 058235/MK-0653)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ezetimibe (SCH 058235/MK-0653), covering 2022-02-17 to 2022-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) [Phase 3]